News
Home | News
WuXi AppTec’s Couvet Site Receives EcoVadis 2024 Silver Medal Rating
November 18, 2024Couvet, Switzerland – November 14, 2024 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries,…
WuXi AppTec Opens New R&D Center in Changzhou, China
November 14, 2024First operational building dedicated to API development for oligonucleotides, peptides, and complex synthetic conjugates. New facility enhances the Company’s drug substance process R&D capacity to drive innovation across all synthetic modalities and…
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
October 30, 2024SHANGHAI, October 29, 2024 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been…
New Enzyme Fermentation Plant in Changshu, China
October 15, 2024We’re excited to announce the latest enhancement to our Early Intermediates manufacturing facility in Changshu, China: a new enzyme fermentation plant that strengthens our biocatalysis capabilities. This expansion increases our total enzyme…
WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers
May 23, 2024Photo caption (from left to right): Ms. Cindy Koh, Executive Vice President, Singapore Economic Development Board; Dr. Minzhang Chen, Co-CEO, WuXi AppTec; Mr. Heng Swee Keat, Deputy Prime Minister; Dr. Ge Li,…
2024 CDMO Leadership Awards
March 21, 2024Exciting moment! We’ve been honored with the 2024 CDMO Leadership Awards in all six core categories: Capabilities, Compatibility, Expertise, Quality, Reliability, and Service, again! Dr. Jinling Chen, our Senior Vice President and Head…
